Navigation Links
PharmAthene Reports Third Quarter 2009 Financial and Operational Results
Date:11/12/2009

comprehensive income 879,759 386,351 Accumulated deficit (150,638,551) (123,817,664) ------------ ------------ Total stockholders' equity 6,486,588 18,963,439 --------- ---------- Total liabilities and stockholders' equity $41,969,842 $56,391,270 =========== ===========
                             PHARMATHENE, INC.
           UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

                            Three months ended            Nine months ended
                               September 30,                 September 30,
                           2009             2008         2009         2008
                           ----             ----         ----         ----

    Contract revenue     $6,830,399    $10,643,705   $20,423,513  $27,377,207
    Other revenue                 -         32,461             -       53,612
                                ---         ------           ---       ------
                          6,830,399     10,676,166    20,423,513   27,430,819
    Operating expenses:
     Research and
      development         7,609,794      9,414,093    22,769,749   26,475,436
     General and
      administrative      6,224,868      4,803,190    15,787,115   14,655,971
     Acquired in-process
      research and
      development                 -        225,000             -   16,131,002
     Depreciation and
      amortization          247,747        205,409       639,924      641,425
     Other expenses         274,005              -     1,158,566            -
                         ----------     ----------    ----------   ----------
     Total operating
      expenses           14,356,414     14,647,692    40,355,354   57,903,834
            
'/>"/>
SOURCE PharmAthene, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
3. PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services
4. Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthenes Legal Action in Breach of Contract Lawsuit Against SIGA
5. PharmAthene to Present at the BIO CEO & Investor Conference 2008
6. PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, Ph.D. Senior Vice President of Operations
7. PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008
8. PharmAthene to Present at the Cowen and Company 28th Annual Health Care Conference
9. PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia
10. PharmAthene to Delay Release of Full Year 2007 Financial Results
11. PharmAthene Year-End 2007 Earnings Conference Call and Webcast Scheduled for Monday, March 31, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... have succeeded in measuring vibrational motion of a single ... how vibration of a single molecule differs from the ... was performed at the University of California, Irvine, where ... works as a visiting fellow under professor Vartkess A. ... team was lead by Professor Eric O. Potma. The ...
(Date:8/20/2014)... August 20, 2014 The 6th ... being held on October 29-30 in San Francisco, CA. ... academic and government researchers and clinicians focused on addressing ... , In the twelve years since the sequencing ... have been introduced with pharmacogenetic information in the label ...
(Date:8/20/2014)... Bulgaria (PRWEB) August 20, 2014 ... was released today including improvements to the enterprise ... and connectors for Lucene, SOLR and Elasticsearch. This ... for this high performance triplestore – GraphDB™ was ... interested in deploying the only mature enterprise resilient ...
(Date:8/19/2014)... August 19, 2014 Cellgen ... raise $200,000 to fund a corporate lab for ... , This development is a critical component in ... care to the implementation of personalized medicine – ... practicing medicine. , Indiegogo contributions will support Cellgen’s ...
Breaking Biology Technology:Seeing a molecule breathe 26th Annual Personalized and Precision Medicine Conference Bringing Together Thought Leaders to Discuss Clinical Implementation, Dx Reimbursement, Big Data, and Sequencing 2Ontotext Improves Its RDF Triplestore, GraphDB™ 6.0: Enterprise Resilience, Faster Loading Speeds and Connectors to Full-Text Search Engines Top the List of Enhancements 2Ontotext Improves Its RDF Triplestore, GraphDB™ 6.0: Enterprise Resilience, Faster Loading Speeds and Connectors to Full-Text Search Engines Top the List of Enhancements 3Ontotext Improves Its RDF Triplestore, GraphDB™ 6.0: Enterprise Resilience, Faster Loading Speeds and Connectors to Full-Text Search Engines Top the List of Enhancements 4Cellgen Diagnostics Launches Indiegogo Crowdfunding Campaign for DNA Medical Testing Device 2Cellgen Diagnostics Launches Indiegogo Crowdfunding Campaign for DNA Medical Testing Device 3
... powered by ForceLogix, on-demand technology, wins Ventana ... and BRACKNELL, U.K., Nov. 12 ForceLogix ... Operational Performance,Leadership Award for Sales, honoring the ... and technology for optimal sales,business impact. ...
... /Xinhua-PRNewswire-FirstCall/ -- Discas, Inc. (Pink,Sheets: DSCS.PK), ("the Company") ... into a stock purchase agreement with SNX Organic ... is Beijing Shen,Nong Xing Technology Co. Ltd. ("BSNX"), ... in the research and development of,green and organic ...
... Lev Pharmaceuticals, Inc.,(OTC Bulletin Board: LEVP.OB) today announced that it will conduct a,conference ... Time (ET), in conjunction with the release of its financial,results for the third ... ET on Tuesday, November 13,2007. DATE: ... 1PM ET ...
Cached Biology Technology:ForceLogix, Innovex Win Sales Operational Performance Award 2ForceLogix, Innovex Win Sales Operational Performance Award 3Discas, Inc. Sells Shares to SNX Organic Fertilizers, Inc. 2Lev Pharmaceuticals Invites You to Participate in its Q3'07 Earnings Results Conference Call and Webcast 2
(Date:8/20/2014)... are athletes who have suffered concussions ready to return ... found that high school athletes who head back on ... a significant regression in their abilities to simultaneously walk ... seen in changes in their balance and/or altered walking ... of the 12 had returned to activity in less ...
(Date:8/20/2014)... 2014) Women who are poor experience higher cortisol ... elevated levels of the stress hormone, putting them ... according to a new research from the University of ... the American Journal of Human Biology , is ... it directly to the socioeconomic status of their mothers ...
(Date:8/20/2014)... and POINT ROBERTS, Washington , ... Play a Key Role in Addressing Security Concerns in the ... a global news source covering leading sectors including biometrics, issues ... market. Jason Peaslee , Managing Partner at ... and Gino Pereira , CEO of NXT-ID, Inc. (OTCBB: ...
Breaking Biology News(10 mins):Recovery reversal seen in Oregon study of returning concussed athletes 2Recovery reversal seen in Oregon study of returning concussed athletes 3CU Denver researcher shows economic disparities impact infant health 2Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 2Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 3Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 4Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 5Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 6Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 7
... from the talents of Rembrandt, Van Gogh and other ... of colors on a palette. In a similar manner, ... (NIST) have created an innovative device called the "microfluidic ... concentration across an areain a miniature chamber about the ...
... WINSTON-SALEM Rates of severe childhood obesity have tripled in ... diabetes and heart disease, according to a report in ... Hospital, part of Wake Forest University Baptist Medical Center. ... obese, which impacts their overall health," said Joseph Skelton, M.D., ...
... Large trees have declined in Yosemite National Park ... play a role. The number of large-diameter trees ... and 1990s. U.S. Geological Survey and University of Washington ... from 1932� to the most recent records from 1988�. ...
Cached Biology News:'Microfluidic palette' may paint clearer picture of biological processes 2Research shows rates of severe childhood obesity have tripled 2
... MBP Coated Microplate, 96 ... Buffer, 5X, #20 Magnesium/ATP Cocktail, #20-11 ... LumiGLO™ Chemiluminescen LumiGLO™ Chemiluminescen ... Quality Assurance: Routinely ...
Rabbit Serum New Zealand or California Origin...
...
... Mouse Serum • Mouse serum is collected off ... and 8-12 weeks of age. Available Anticoagulants: ... N-06: K2EDTA N-08: Potassium Oxalate ... N-05: ACD N-07: CPD ...
Biology Products: